Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-16

Clinical Trial Update: FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the use of fludrocortisone for aneurysmal subarachnoid hemorrhage. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fludrocortisone (Fludrocortisone)

Snippet

Sponsor: The George Institute | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 2 | Status: RECRUITING